Samuraciclib trihydrochloride
≥98%
- Product Code: 102465
Alias:
Related CAS: 1805833-75-3, 1805789-54-1; CT7001 trihydrochloride; ICEC0942 trihydrochloride; CT-7001 trihydrochloride; ICEC-0942 trihydrochloride
| Molecular Weight: | 503.90 g./mol | Molecular Formula: | C₂₂H₃₃Cl₃N₆O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Samuraciclib trihydrochloride is primarily used in the field of oncology as a cyclin-dependent kinase (CDK) inhibitor. It is being investigated for its potential to treat various types of cancers, particularly those that are hormone receptor-positive, such as breast cancer. By inhibiting CDK7, this compound disrupts the cell cycle and transcription processes in cancer cells, leading to their growth arrest and apoptosis. Clinical trials are ongoing to evaluate its efficacy and safety as a monotherapy or in combination with other anticancer agents. Its application aims to provide a targeted therapeutic option for patients with resistant or recurrent cancers, offering a potential improvement in treatment outcomes.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿21,240.00 |
+
-
|
| 0.025 | 10-20 days | ฿78,120.00 |
+
-
|
Samuraciclib trihydrochloride
Samuraciclib trihydrochloride is primarily used in the field of oncology as a cyclin-dependent kinase (CDK) inhibitor. It is being investigated for its potential to treat various types of cancers, particularly those that are hormone receptor-positive, such as breast cancer. By inhibiting CDK7, this compound disrupts the cell cycle and transcription processes in cancer cells, leading to their growth arrest and apoptosis. Clinical trials are ongoing to evaluate its efficacy and safety as a monotherapy or in combination with other anticancer agents. Its application aims to provide a targeted therapeutic option for patients with resistant or recurrent cancers, offering a potential improvement in treatment outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :